ArticleHuman vaccines & immunotherapeutics2025
Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- State of human papilloma virus vaccine uptake among girls (15-21 years) in Zambia: analysis of a 2024 national survey.Journal of health, population, and nutrition · 2026Article
- Human Papillomavirus Vaccination Coverage Estimates Among the Primary Target Cohort (9-14-Year-Old Girls) in the World (2010-2024).Vaccines · 2025Article
- Mind the Gap: Sex-Specific Drivers of Human Papillomavirus Vaccination Uptake in Serbian University Students.European journal of investigation in health, psychology and education · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HPV is a common sexually transmitted infection (STI), often affecting young women. Although most infections are asymptomatic, high-risk types of HPV can cause multiple types of cancer, especially cervical cancer. Brazil's 2014 national HPV vaccination campaign, targeting girls aged 11 to 13, improved awareness and vaccine coverage. However, challenges such as vaccine hesitancy and the ongoing need for educational interventions persist, highlighting the need for additional studies to better understand factors influencing vaccine uptake among adolescents. This study analyzed data from the 2019 PeNSE survey, focusing on HPV vaccination information in the dataset. It also examined factors like socioeconomic conditions, family context, and access to education and healthcare. The study found that access to information through cellphones increased HPV vaccine uptake, particularly among females. Indigenous adolescents had higher vaccination odds compared to White adolescents, likely due to campaigns that aimed at vulnerable individuals. Overall, any degree of maternal schooling, compared to no formal education, was related to higher odds of being vaccinated. Sexual health education, particularly on pregnancy prevention and STIs, also boosted vaccine uptake, likely due to overlapping content that includes HPV-related information. The student population presents an opportunity for improving HPV vaccination coverage through parental and school education, healthcare information, and targeted optimization strategies for both genders. Future studies should be designed to leverage these opportunities to achieve the WHO goal of 90% vaccination coverage among girls by age 15 by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.